Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Buy
6,824
+1,324
+24% +$253K 0.03% 394
2026
Q1
$1.01M Sell
5,500
-5,422
-50% -$999K 0.03% 419
2025
Q4
$1.92M Buy
10,922
+6,141
+128% +$1M 0.06% 244
2025
Q3
$670K Buy
4,781
+1,402
+41% +$190K 0.02% 466
2025
Q2
$424K Sell
3,379
-846
-20% -$105K 0.01% 508
2025
Q1
$578K Sell
4,225
-186
-4% -$26.6K 0.03% 334
2024
Q4
$675K Buy
+4,411
New +$744K 0.04% 293

Other funds holding BIIB

SIG Brokerage's BIIB Position: Q2 2026 in Review

SIG Brokerage increased its Biogen (BIIB) stake by 24% in Q2 2026, buying an estimated $253K and bringing the position to 6,824 shares worth $1.47M. The position accounts for 0.03% of the portfolio, ranked #394.

SIG Brokerage first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.92M in Q4 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • SIG Brokerage held 6,824 shares of Biogen worth $1.47M as of Q2 2026.
  • SIG Brokerage bought 1,324 Biogen shares in Q2 2026, an estimated $253K.
  • Biogen made up 0.03% of SIG Brokerage's portfolio in Q2 2026, its #394 holding.
  • SIG Brokerage first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • SIG Brokerage's Biogen position peaked at $1.92M in Q4 2025.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.